Route of Administration (Grade): Parenteral, Oral, Ophthalmic, Nasal, Topical, Oral and Inhalation.
Pharmacopoeia Reference: USP NF
Technical Specifications: Captisol® is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE).
INJECTABLE;INJECTION - EQ 50MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**